Table of Contents Executive Summary 1 Industry Overview of Immune Checkpoint Blockers 1.1 Definition of Immune Checkpoint Blockers 1.2 Immune Checkpoint Blockers Segment by Type 1.2.1 Global Immune Checkpoint Blockers Production Growth Rate Comparison by Types (2014-2025) 1.2.2 Anti-PD-L1 Drug 1.2.3 Anti-PD-1 Drug 1.2.4 CTLA4 1.3 Immune Checkpoint Blockers Segment by Applications 1.3.1 Global Immune Checkpoint Blockers Consumption Comparison by Applications (2014-2025) 1.3.2 Lung Cancer 1.3.3 Colorectal Cancer 1.3.4 Breast Cancer  1.3.5 Prostate Cancer 1.3.6 Melanoma 1.3.7 Blood Cancers 1.4 Global Immune Checkpoint Blockers Overall Market 1.4.1 Global Immune Checkpoint Blockers Revenue (2014-2025) 1.4.2 Global Immune Checkpoint Blockers Production (2014-2025) 1.4.3 North America Immune Checkpoint Blockers Status and Prospect (2014-2025) 1.4.4 Europe Immune Checkpoint Blockers Status and Prospect (2014-2025) 1.4.5 China Immune Checkpoint Blockers Status and Prospect (2014-2025) 1.4.6 Japan Immune Checkpoint Blockers Status and Prospect (2014-2025) 1.4.7 Southeast Asia Immune Checkpoint Blockers Status and Prospect (2014-2025) 1.4.8 India Immune Checkpoint Blockers Status and Prospect (2014-2025) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Immune Checkpoint Blockers 2.3 Manufacturing Process Analysis of Immune Checkpoint Blockers 2.4 Industry Chain Structure of Immune Checkpoint Blockers 3 Development and Manufacturing Plants Analysis of Immune Checkpoint Blockers 3.1 Capacity and Commercial Production Date 3.2 Global Immune Checkpoint Blockers Manufacturing Plants Distribution 3.3 Major Manufacturers Technology Source and Market Position of Immune Checkpoint Blockers 3.4 Recent Development and Expansion Plans 4 Key Figures of Major Manufacturers 4.1 Immune Checkpoint Blockers Production and Capacity Analysis 4.2 Immune Checkpoint Blockers Revenue Analysis 4.3 Immune Checkpoint Blockers Price Analysis 4.4 Market Concentration Degree 5 Immune Checkpoint Blockers Regional Market Analysis 5.1 Immune Checkpoint Blockers Production by Regions 5.1.1 Global Immune Checkpoint Blockers Production by Regions 5.1.2 Global Immune Checkpoint Blockers Revenue by Regions 5.2 Immune Checkpoint Blockers Consumption by Regions 5.3 North America Immune Checkpoint Blockers Market Analysis 5.3.1 North America Immune Checkpoint Blockers Production 5.3.2 North America Immune Checkpoint Blockers Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America Immune Checkpoint Blockers Import and Export 5.4 Europe Immune Checkpoint Blockers Market Analysis 5.4.1 Europe Immune Checkpoint Blockers Production 5.4.2 Europe Immune Checkpoint Blockers Revenue 5.4.3 Key Manufacturers in Europe 5.4.4 Europe Immune Checkpoint Blockers Import and Export 5.5 China Immune Checkpoint Blockers Market Analysis 5.5.1 China Immune Checkpoint Blockers Production 5.5.2 China Immune Checkpoint Blockers Revenue 5.5.3 Key Manufacturers in China 5.5.4 China Immune Checkpoint Blockers Import and Export 5.6 Japan Immune Checkpoint Blockers Market Analysis 5.6.1 Japan Immune Checkpoint Blockers Production 5.6.2 Japan Immune Checkpoint Blockers Revenue 5.6.3 Key Manufacturers in Japan 5.6.4 Japan Immune Checkpoint Blockers Import and Export 5.7 Southeast Asia Immune Checkpoint Blockers Market Analysis 5.7.1 Southeast Asia Immune Checkpoint Blockers Production 5.7.2 Southeast Asia Immune Checkpoint Blockers Revenue 5.7.3 Key Manufacturers in Southeast Asia 5.7.4 Southeast Asia Immune Checkpoint Blockers Import and Export 5.8 India Immune Checkpoint Blockers Market Analysis 5.8.1 India Immune Checkpoint Blockers Production 5.8.2 India Immune Checkpoint Blockers Revenue 5.8.3 Key Manufacturers in India 5.8.4 India Immune Checkpoint Blockers Import and Export 6 Immune Checkpoint Blockers Segment Market Analysis (by Type) 6.1 Global Immune Checkpoint Blockers Production by Type 6.2 Global Immune Checkpoint Blockers Revenue by Type 6.3 Immune Checkpoint Blockers Price by Type 7 Immune Checkpoint Blockers Segment Market Analysis (by Application) 7.1 Global Immune Checkpoint Blockers Consumption by Application 7.2 Global Immune Checkpoint Blockers Consumption Market Share by Application (2014-2019) 8 Immune Checkpoint Blockers Major Manufacturers Analysis 8.1 Bristol Myers Squibb 8.1.1 Bristol Myers Squibb Immune Checkpoint Blockers Production Sites and Area Served 8.1.2 Bristol Myers Squibb Product Introduction, Application and Specification 8.1.3 Bristol Myers Squibb Immune Checkpoint Blockers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.1.4 Main Business and Markets Served 8.2 Merck 8.2.1 Merck Immune Checkpoint Blockers Production Sites and Area Served 8.2.2 Merck Product Introduction, Application and Specification 8.2.3 Merck Immune Checkpoint Blockers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.2.4 Main Business and Markets Served 8.3 AstraZeneca 8.3.1 AstraZeneca Immune Checkpoint Blockers Production Sites and Area Served 8.3.2 AstraZeneca Product Introduction, Application and Specification 8.3.3 AstraZeneca Immune Checkpoint Blockers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.3.4 Main Business and Markets Served 8.4 Roche 8.4.1 Roche Immune Checkpoint Blockers Production Sites and Area Served 8.4.2 Roche Product Introduction, Application and Specification 8.4.3 Roche Immune Checkpoint Blockers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.4.4 Main Business and Markets Served 9 Development Trend of Analysis of Immune Checkpoint Blockers Market 9.1 Global Immune Checkpoint Blockers Market Trend Analysis 9.1.1 Global Immune Checkpoint Blockers Market Size (Volume and Value) Forecast 2019-2025 9.2 Immune Checkpoint Blockers Regional Market Trend 9.2.1 North America Immune Checkpoint Blockers Forecast 2019-2025 9.2.2 Europe Immune Checkpoint Blockers Forecast 2019-2025 9.2.3 China Immune Checkpoint Blockers Forecast 2019-2025 9.2.4 Japan Immune Checkpoint Blockers Forecast 2019-2025 9.2.5 Southeast Asia Immune Checkpoint Blockers Forecast 2019-2025 9.2.6 India Immune Checkpoint Blockers Forecast 2019-2025 9.3 Immune Checkpoint Blockers Market Trend (Product Type) 9.4 Immune Checkpoint Blockers Market Trend (Application) 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.3 Immune Checkpoint Blockers Customers 11 Market Dynamics 11.1 Market Trends 11.2 Opportunities 11.3 Market Drivers 11.4 Challenges 11.5 Influence Factors 12 Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer

List of Tables and Figures Figure Picture of Immune Checkpoint Blockers Table Global Immune Checkpoint Blockers Production (K Units) Growth Rate Comparison by Types (2014-2025) Figure Global Immune Checkpoint Blockers Production Market Share by Types in 2018 Figure Anti-PD-L1 Drug Product Picture Figure Anti-PD-1 Drug Product Picture Figure CTLA4 Product Picture Table Global Immune Checkpoint Blockers Consumption (K Units) Comparison by Applications (2014-2025) Figure Global Immune Checkpoint Blockers Consumption Market Share by Applications in 2018 Figure Lung Cancer Figure Colorectal Cancer Figure Breast Cancer  Figure Prostate Cancer Figure Melanoma Figure Blood Cancers Figure Global Immune Checkpoint Blockers Revenue (Million USD) (2014-2025) Figure Global Immune Checkpoint Blockers Production (K Units) (2014-2025) Figure North America Immune Checkpoint Blockers Market Size (Million USD) (2014-2025) Figure Europe Immune Checkpoint Blockers Market Size (Million USD) (2014-2025) Figure China Immune Checkpoint Blockers Market Size (Million USD) (2014-2025) Figure Japan Immune Checkpoint Blockers Market Size (Million USD) (2014-2025) Figure Southeast Asia Immune Checkpoint Blockers Market Size (Million USD) (2014-2025) Figure India Immune Checkpoint Blockers Market Size (Million USD) (2014-2025) Table Immune Checkpoint Blockers Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of Immune Checkpoint Blockers in 2018 Figure Manufacturing Process Analysis of Immune Checkpoint Blockers Figure Industry Chain Structure of Immune Checkpoint Blockers Table Capacity and Commercial Production Date of Key Manufacturers Table Global Immune Checkpoint Blockers Manufacturing Plants Distribution Table Immune Checkpoint Blockers Major Manufacturers Technology Source and Market Position Table Recent Development and Expansion Plans in Future Table Immune Checkpoint Blockers Capacity (K Units) of Major Manufacturers (2014-2019) Table Immune Checkpoint Blockers Production (K Units) of Major Manufacturers (2014-2019) Table Immune Checkpoint Blockers Production Market Share of Major Manufacturers (2014-2019) Figure Immune Checkpoint Blockers Production Share by Manufacturers in 2018 Table Immune Checkpoint Blockers Revenue (Million US$) of Major Manufacturers (2014-2019) Table Immune Checkpoint Blockers Revenue Market Share of Major Manufacturers (2014-2019) Figure Immune Checkpoint Blockers Revenue Share by Manufacturers in 2018 Table Immune Checkpoint Blockers Average Price (USD/Unit) of Major Manufacturers (2014-2019) Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Global Immune Checkpoint Blockers Production by Regions 2014-2019 (K Units) Table Global Immune Checkpoint Blockers Production Market Share by Regions 2014-2019 Figure Global Immune Checkpoint Blockers Production Market Share by Regions in 2018 Table Global Immune Checkpoint Blockers Revenue by Regions 2014-2019 (Million USD) Table Global Immune Checkpoint Blockers Revenue Market Share by Regions 2014-2019 Figure Global Immune Checkpoint Blockers Revenue Market Share by Regions in 2018 Table Global Immune Checkpoint Blockers Consumption by Regions 2014-2019 (K Units) Table Global Immune Checkpoint Blockers Consumption Market Share by Regions 2014-2019 Figure North America Immune Checkpoint Blockers Production Growth Rate 2014-2019 (K Units) Figure North America Immune Checkpoint Blockers Revenue Growth Rate 2014-2019 (Million USD) Table North America Immune Checkpoint Blockers Production, Consumption Import and Export (K Units) Figure Europe Immune Checkpoint Blockers Production Growth Rate 2014-2019 (K Units) Figure Europe Immune Checkpoint Blockers Revenue Growth Rate 2014-2019 (Million USD) Table Europe Immune Checkpoint Blockers Production, Consumption Import and Export (K Units) Figure China Immune Checkpoint Blockers Production Growth Rate 2014-2019 (K Units) Figure China Immune Checkpoint Blockers Revenue Growth Rate 2014-2019 (Million USD) Table China Immune Checkpoint Blockers Production, Consumption Import and Export (K Units) Figure Japan Immune Checkpoint Blockers Production Growth Rate 2014-2019 (K Units) Figure Japan Immune Checkpoint Blockers Revenue Growth Rate 2014-2019 (Million USD) Table Japan Immune Checkpoint Blockers Production, Consumption Import and Export (K Units) Figure Southeast Asia Immune Checkpoint Blockers Production Growth Rate 2014-2019 (K Units) Figure Southeast Asia Immune Checkpoint Blockers Revenue Growth Rate 2014-2019 (Million USD) Table Southeast Asia Immune Checkpoint Blockers Production, Consumption Import and Export (K Units) Figure India Immune Checkpoint Blockers Production Growth Rate 2014-2019 (K Units) Figure India Immune Checkpoint Blockers Revenue Growth Rate 2014-2019 (Million USD) Table India Immune Checkpoint Blockers Production, Consumption Import and Export (K Units) Figure Global Consumption Immune Checkpoint Blockers Market Share by Application (2014-2019) Figure Global Value (Consumption) Immune Checkpoint Blockers Market Share by Application (2014-2019) Table Bristol Myers Squibb Immune Checkpoint Blockers Production Sites and Area Served Table Bristol Myers Squibb Immune Checkpoint Blockers Product Introduction, Application and Specification Table Bristol Myers Squibb Immune Checkpoint Blockers Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Bristol Myers Squibb Immune Checkpoint Blockers Production Growth Rate (2014-2019) Table Bristol Myers Squibb Immune Checkpoint Blockers Production Market Share (2014-2019) Figure Bristol Myers Squibb Immune Checkpoint Blockers Revenue Market Share (2014-2019) Table Bristol Myers Squibb Immune Checkpoint Blockers Main Business and Markets Served Table Merck Immune Checkpoint Blockers Production Sites and Area Served Table Merck Immune Checkpoint Blockers Product Introduction, Application and Specification Table Merck Immune Checkpoint Blockers Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Merck Immune Checkpoint Blockers Production Growth Rate (2014-2019) Table Merck Immune Checkpoint Blockers Production Market Share (2014-2019) Figure Merck Immune Checkpoint Blockers Revenue Market Share (2014-2019) Table Merck Immune Checkpoint Blockers Main Business and Markets Served Table AstraZeneca Immune Checkpoint Blockers Production Sites and Area Served Table AstraZeneca Immune Checkpoint Blockers Product Introduction, Application and Specification Table AstraZeneca Immune Checkpoint Blockers Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table AstraZeneca Immune Checkpoint Blockers Production Growth Rate (2014-2019) Table AstraZeneca Immune Checkpoint Blockers Production Market Share (2014-2019) Figure AstraZeneca Immune Checkpoint Blockers Revenue Market Share (2014-2019) Table AstraZeneca Immune Checkpoint Blockers Main Business and Markets Served Table Roche Immune Checkpoint Blockers Production Sites and Area Served Table Roche Immune Checkpoint Blockers Product Introduction, Application and Specification Table Roche Immune Checkpoint Blockers Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Roche Immune Checkpoint Blockers Production Growth Rate (2014-2019) Table Roche Immune Checkpoint Blockers Production Market Share (2014-2019) Figure Roche Immune Checkpoint Blockers Revenue Market Share (2014-2019) Table Roche Immune Checkpoint Blockers Main Business and Markets Served Figure Global Immune Checkpoint Blockers Production (K Units) Growth Rate Forecast 2019-2025 Figure Global Immune Checkpoint Blockers Revenue (Million USD) Growth Rate Forecast 2019-2025 Figure Global Immune Checkpoint Blockers Sales Price (USD/Unit) Forecast 2019-2025 Figure North America Immune Checkpoint Blockers Production Growth Rate Forecast 2019-2025 (K Units) Figure North America Immune Checkpoint Blockers Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Europe Immune Checkpoint Blockers Production Growth Rate Forecast 2019-2025 (K Units) Figure Europe Immune Checkpoint Blockers Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure China Immune Checkpoint Blockers Production Growth Rate Forecast 2019-2025 (K Units) Figure China Immune Checkpoint Blockers Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Japan Immune Checkpoint Blockers Production Growth Rate Forecast 2019-2025 (K Units) Figure Japan Immune Checkpoint Blockers Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Southeast Asia Immune Checkpoint Blockers Production Growth Rate Forecast 2019-2025 (K Units) Figure Southeast Asia Immune Checkpoint Blockers Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure India Immune Checkpoint Blockers Production Growth Rate Forecast 2019-2025 (K Units) Figure India Immune Checkpoint Blockers Revenue Growth Rate Forecast 2019-2025 (Million USD) Table Global Production (K Units) of Immune Checkpoint Blockers by Type (2019-2025) Table Global Consumption (K Units) of Immune Checkpoint Blockers by Application (2019-2025) Table Immune Checkpoint Blockers Distributors List Table Immune Checkpoint Blockers Customers List Table Market Key Trends Table Key Opportunities Table Market Key Drivers Table Key Challenges Table Key Influence Factors Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Bristol Myers Squibb Merck AstraZeneca Roche